相关实验视频

Updated: Jan 17, 2026

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
05:30

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion

Published on: February 14, 2025

1.5K

肥胖对同时进行双边膝关节关节整形手术的影响

Bedrettin Akar1, Yusuf Oztürkmen, Mehmet B Balioglu

  • 1From the Department of Orthopedics and Traumatology, Sakarya Yenikent State Hospital, Sakarya, Turkey (Dr. Akar); Department of Orthopedics and Traumatology, Istanbul Training and Research Hospital, Istanbul, Turkey (Dr. Oztürkmen); Department of Orthopedics and Traumatology, Basaksehir Cam Sakura City Hospital, Istanbul, Turkey (Dr. Balioglu); Department of Orthopedics and Traumatology, Kastamonu University Faculty of Medicine, Kastamonu, Turkey (Dr. Ugur); and Deparmant of Orthopedics and Traumatology, Biruni University, Istanbul, Turkey (Dr. Sükür).

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews
|September 22, 2025
PubMed
概括

肥胖不会显著影响同时双边全膝关节整形术 (SBTKA) 的结果. 在这项研究中,肥胖患者的临床结果和整体并发症率与非肥胖患者相似.

更多相关视频

The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve09:51

The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve

Published on: September 7, 2022

3.5K

相关概念视频

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169